Last week, Speaker Paul Ryan (R-Wis.) announced that he would not seek re-election. His future had been an open question. He was essentially recruited to take the gavel of the chamber after Speaker John Boehner (R-Ohio) called it quits in October 2015.

President Obama’s “Clean Power Plan” (CPP) drains our economy for Sierra Club hysteria. CPP sacrifices thousands of jobs, billions in growth, and lots of happiness. Thankfully, Environmental Protection Agency (EPA) Administrator Scott Pruitt will likely toss it.

In a press conference on Friday, President Donald Trump criticized the process that Congress used to pass the Consolidated Appropriations Act, H.R. 1625, although he signed the spending bill into law. Still, he threatened to veto a future spending bill that was packed with wasteful spending and unrelated legislative priorities.

In 2015, Congressman Mark Meadows (R-N.C.) started a movement to remove then-Speaker of the House, John Boehner (R-Ohio), from his position. Of this effort, Meadows said, "It's really more about trying to have a conversation on making this place work, where everybody's voice matters, where there's not a punitive culture. Hopefully, we'll have some discussion about that in the days and weeks to come."

Republicans in Congress have retreated on their pledges to cut spending. How else should one interpret the passage of the Bipartisan Budget Act, H.R. 1892, last week? The bill busts the spending caps by $296 billion over two years ($165 billion for defense and $131 billion for nondefense). Congress added another $80 billion in disaster relief, bringing the total to at least $376 billion.

In his State of the Union address one week ago today, President Donald Trump touted the widespread successes of tax reform legislation as well as his impressive rollback of regulatory burdens. FreedomWorks applauds those successes, and encourages Congress to advance further successes of the president’s agenda, as presented in his speech.

In his first State of the Union speech, President Trump once again promised to lower the swelling costs of prescription drugs. The question is – will the administration do it without imposing price controls.